Answers are grounded in this paper and cite their sources.
Maintenance of atrial fibrillation is a complex mechanism, including extensive electrical and structural remodeling of the atria which involves progressive fibrogenesis. Galectin-3 is a biomarker of fibrosis, and, thus, may be involved in atrial remodeling in atrial fibrillation patients. We review the role of galectin-3 in AF mechanisms and its potential therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Clémenty et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: